P. Sepulveda et al., Modulation of cardiocyte functional activity by antibodies against Trypanosoma cruzi ribosomal P2 protein C terminus, INFEC IMMUN, 68(9), 2000, pp. 5114-5119
Antibodies against the Trpanosoma cruzi ribosomal P2 beta protein (TcP2 bet
a) have been associated with the chronic cardiac pathology of Chagas' disea
se in humans. Using synthetic peptides spanning the entire TcP2 beta molecu
le, we investigated their epitope recognition by antibodies from mice chron
ically infected with T. cruzi and from mice immunized with two recombinant
TcP2 beta s. We found clear differences in epitope recognition between anti
bodies from T. cruzi-infected mice and mice immunized with two different re
combinant TcP2 beta s associated with different schedules of immunization.
Major epitopes recognized by antibodies from mice immunized with recombinan
t glutathione S-transferase (GST) or histidine (Hist) fusion TcP2 beta (GST
-TcP2 beta or Hist-TcP2 beta) are located in the central and hinge regions
of the molecule. Nevertheless, mice immunized with Hist-TcP2 beta mere also
able to elicit antibodies against the TcP2 beta C terminus, a region which
is highly conserved in both T. cruzi and mammal ribosomal P proteins. Stri
kingly, antibodies from infected animals recognized only the TcP2 beta C te
rminus. By using these antisera with distinct profiles of epitope recogniti
on, it could be shown that only C terminus-specific antibodies mere able to
increase the beating frequency of cardiomyocytes from neonatal rats in vit
ro by selective stimulation of the beta 1-adrenergic receptor. Thus, antibo
dies against the TcP2 beta C terminus elicited in the absence of infection
are able to modulate a functional activity of host cells through a molecula
r mimicry mechanism.